BioCryst Pharmaceuticals Inc – Strategy, SWOT and Corporate Finance Report

BioCryst Pharmaceuticals Inc – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360Ëš view of the company.

BioCryst Pharmaceuticals Inc (BioCryst) designs, optimizes and develops small molecule drugs that block key enzymes in the pathogenesis of diseases. The company focuses on the treatment of rare diseases and develops drugs for infectious diseases and hereditary Angioedemaon. It integrates disciplines of biology, crystallography, medicinal chemistry and computer modeling to discover and develop small molecule pharmaceuticals through the process known as structure-guided drug design. BioCryst’s products include peramivir injections, which consists of Rapivab, Alpivab, Rapiacta and Peramiflu for the treatment of Influenza. The company has strategic partnerships with corporate and academic institutes. BioCryst has research operations in Birmingham, Alabama and is headquartered in Durham, North Carolina, the US.

Scope

Detailed information on BioCryst Pharmaceuticals Inc required for business and competitor intelligence needs

A study of the major internal and external factors affecting BioCryst Pharmaceuticals Inc in the form of a SWOT analysis

An in-depth view of the business model of BioCryst Pharmaceuticals Inc including a breakdown and examination of key business segments

News about BioCryst Pharmaceuticals Inc, such as business expansion, restructuring, and contract wins

Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

Gain understanding of BioCryst Pharmaceuticals Inc and the factors that influence its strategies.

Track strategic initiatives of the company and latest corporate news and actions.

Assess BioCryst Pharmaceuticals Inc as a prospective partner, vendor or supplier.

Support sales activities by understanding your customers' businesses better.

Stay up to date on BioCryst Pharmaceuticals Incs business structure, strategy and prospects.

Note: Some sections may be missing if data is unavailable for the company.

Companies mentioned

Daiichi Sankyo Co Ltd

GlaxoSmithKline Plc

F. Hoffmann-La Roche Ltd

Shire Plc

Gilead Sciences Inc

Arbutus Biopharma Corp

Ionis Pharmaceuticals Inc

Mapp Biopharmaceutical Inc

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1 - About the Company

BioCryst Pharmaceuticals Inc - Key Facts

BioCryst Pharmaceuticals Inc - Key Employees

BioCryst Pharmaceuticals Inc - Key Employee Biographies

BioCryst Pharmaceuticals Inc - Major Products and Services

BioCryst Pharmaceuticals Inc - History

BioCryst Pharmaceuticals Inc - Company Statement

BioCryst Pharmaceuticals Inc - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2 Company Analysis

Company Overview

BioCryst Pharmaceuticals Inc - Business Description

BioCryst Pharmaceuticals Inc - Corporate Strategy

BioCryst Pharmaceuticals Inc - SWOT Analysis

SWOT Analysis - Overview

BioCryst Pharmaceuticals Inc - Strengths

BioCryst Pharmaceuticals Inc - Weaknesses

BioCryst Pharmaceuticals Inc - Opportunities

BioCryst Pharmaceuticals Inc - Threats

BioCryst Pharmaceuticals Inc - Key Competitors

Section 3 Company Financial Ratios

Financial Ratios - Capital Market Ratios

Financial Ratios - Annual Ratios

Performance Chart

Financial Performance

Financial Ratios - Interim Ratios

Financial Ratios - Ratio Charts

Section 4 Company’s Lifesciences Financial Deals and Alliances

BioCryst Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

BioCryst Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

BioCryst Pharmaceuticals Inc, Recent Deals Summary

Section 5 Company’s Recent Developments

Mar 04, 2019: BioCryst reports fourth quarter and full year 2018 financial results

Jan 04, 2019: BioCryst appoints Steve Aselage to Board of Directors

Jan 02, 2019: BioCryst Initiates Phase 1 Clinical Trial of Galidesivir

Nov 20, 2018: BioCryst Pharmaceuticals names Theresa Heggie as Board Director

Nov 06, 2018: BioCryst reports third quarter 2018 financial results

Sep 17, 2018: ASLAN Pharmaceuticals Provides Update on Timelines for Clinical Trial of Varlitinib in Biliary Tract Cancer in China[Newswire : Healthcare - GNW RSS]

Sep 17, 2018: PCI Biotech: Prospectus approved[Newswire : Healthcare - GNW RSS]

Sep 17, 2018: Large European real-world study reports effects of Spiolto® Respimat® for people living with COPD in daily clinical practice1[Newswire : Healthcare-BW]

Sep 17, 2018: Virion Appoints Vanessa King as President & CEO and Isabel Najera as CSO[Newswire : Healthcare-BW]

Section 6 Appendix

Methodology

Ratio Definitions

About GlobalData

Contact Us

Disclaimer

List of Tables

BioCryst Pharmaceuticals Inc, Key Facts

BioCryst Pharmaceuticals Inc, Key Employees

BioCryst Pharmaceuticals Inc, Key Employee Biographies

BioCryst Pharmaceuticals Inc, Major Products and Services

BioCryst Pharmaceuticals Inc, History

BioCryst Pharmaceuticals Inc, Other Locations

BioCryst Pharmaceuticals Inc, Subsidiaries

BioCryst Pharmaceuticals Inc, Key Competitors

BioCryst Pharmaceuticals Inc, Ratios based on current share price

BioCryst Pharmaceuticals Inc, Annual Ratios

BioCryst Pharmaceuticals Inc, Annual Ratios (Cont…1)

BioCryst Pharmaceuticals Inc, Interim Ratios

BioCryst Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

BioCryst Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

BioCryst Pharmaceuticals Inc, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

List of Figures

BioCryst Pharmaceuticals Inc, Performance Chart (2014 – 2018)

BioCryst Pharmaceuticals Inc, Ratio Charts

BioCryst Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

BioCryst Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019

    Pricing

Discounts available for multiple report purchases.

reportstore@marketline.com
+44 (0) 161 359 5817

Saved reports